84 related articles for article (PubMed ID: 6216992)
1. Failure of malaria vaccination in mice born to immune mothers.
Harte PG; De Souza JB; Playfair JH
Clin Exp Immunol; 1982 Sep; 49(3):509-16. PubMed ID: 6216992
[TBL] [Abstract][Full Text] [Related]
2. Failure of malaria vaccination in mice born to immune mothers. II. Induction of specific suppressor cells by maternal IgG.
Harte PG; Playfair JH
Clin Exp Immunol; 1983 Jan; 51(1):157-64. PubMed ID: 6219839
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity.
Playfair JH; De Souza JB; Freeman RR; Holder AA
Clin Exp Immunol; 1985 Oct; 62(1):19-23. PubMed ID: 2933196
[TBL] [Abstract][Full Text] [Related]
4. Maternal inhibition of malaria vaccination in mice can be overcome by giving a second dose of vaccine.
Harte PG; Rogers N; Targett GA; Playfair JH
Immunology; 1984 Nov; 53(3):401-9. PubMed ID: 6237985
[TBL] [Abstract][Full Text] [Related]
5. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
Hirunpetcharat C; Vukovic P; Liu XQ; Kaslow DC; Miller LH; Good MF
J Immunol; 1999 Jun; 162(12):7309-14. PubMed ID: 10358180
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses in mice protected against malaria by vaccination.
Playfair JH; De Souza JB
Parasite Immunol; 1979; 1(3):197-208. PubMed ID: 399336
[TBL] [Abstract][Full Text] [Related]
8. Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development.
Kumar S; Good MF; Dontfraid F; Vinetz JM; Miller LH
J Immunol; 1989 Sep; 143(6):2017-23. PubMed ID: 2570802
[TBL] [Abstract][Full Text] [Related]
9. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
10. [Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii].
Yuan J; Xu B; Liu BF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):47-51. PubMed ID: 15052774
[TBL] [Abstract][Full Text] [Related]
11. Passive immunization against murine malaria with an IgG3 monoclonal antibody.
Majarian WR; Daly TM; Weidanz WP; Long CA
J Immunol; 1984 Jun; 132(6):3131-7. PubMed ID: 6725950
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice.
Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM
Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767
[TBL] [Abstract][Full Text] [Related]
13. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
[TBL] [Abstract][Full Text] [Related]
14. Defective resistance to Plasmodium yoelii in CBA/N mice.
Hunter KW; Finkelman FD; Strickland GT; Sayles PC; Scher I
J Immunol; 1979 Jul; 123(1):133-7. PubMed ID: 448143
[TBL] [Abstract][Full Text] [Related]
15. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
Burns JM; Flaherty PR; Nanavati P; Weidanz WP
Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
[TBL] [Abstract][Full Text] [Related]
16. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
Aly AS; Downie MJ; Mamoun CB; Kappe SH
Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
[TBL] [Abstract][Full Text] [Related]
17. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
18. Influence of Toxocara canis infection during pregnancy on offspring resistance towards re-infection.
Reiterová K; Tomasovicová O; Dubinský P
Parasitology; 2006 May; 132(Pt 5):625-33. PubMed ID: 16426482
[TBL] [Abstract][Full Text] [Related]
19. Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei.
Playfair JH; De Souza JB; Cottrell BJ
Immunology; 1977 Oct; 33(4):507-15. PubMed ID: 336522
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model.
Cherif MS; Shuaibu MN; Kodama Y; Kurosaki T; Helegbe GK; Kikuchi M; Ichinose A; Yanagi T; Sasaki H; Yui K; Tien NH; Karbwang J; Hirayama K
Vaccine; 2014 Apr; 32(17):1998-2006. PubMed ID: 24440206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
